Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now
Read now
Neil C Thomson. (2018) Challenges in the management of asthma associated with smoking-induced airway diseases. Expert Opinion on Pharmacotherapy 19:14, pages 1565-1579.
Read now
Read now
Yang Xia, Wen Li & Huahao Shen. (2017) Anti-IgE therapy as novel target for asthma-COPD overlap syndrome: More questions before celebration. Journal of Asthma 54:2, pages 113-113.
Read now
Read now
Articles from other publishers (17)
Vicente Plaza Moral, Isam Alobid, Cesáreo Álvarez Rodríguez, Marina Blanco Aparicio, Jorge Ferreira, Gabriel García, Antonio Gómez-Outes, Noé Garín Escrivá, Fernando Gómez Ruiz, Antonio Hidalgo Requena, Javier Korta Murua, Jesús Molina París, Francisco Javier Pellegrini Belinchón, Javier Plaza Zamora, Manuel Praena Crespo, Santiago Quirce Gancedo, José Sanz Ortega & José Gregorio Soto Campos. (2023) GEMA 5.3. Spanish Guideline on the Management of Asthma. Open Respiratory Archives 5:4, pages 100277.
Crossref
Crossref
Ahmad R. Alsayed, Mahmoud S. Abu-Samak & Mohammad Alkhatib. (2023) Asthma-COPD Overlap in Clinical Practice (ACO_CP 2023): Toward Precision Medicine. Journal of Personalized Medicine 13:4, pages 677.
Crossref
Crossref
Nicola A. Hanania & Marc Miravitlles. (2022) Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunology and Allergy Clinics of North America 42:3, pages 657-669.
Crossref
Crossref
Evangelia Fouka, Andriana I. Papaioannou, Georgios Hillas & Paschalis Steiropoulos. (2022) Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions. Journal of Personalized Medicine 12:5, pages 708.
Crossref
Crossref
Borja G Cosio & Hanaa Shafiek. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
702
711
.
Hikaru Toyota, Naoya Sugimoto, Konomi Kobayashi, Yuki Suzuki, Yuri Takeshita, Ayaka Ito, Mariko Ujino, Fuminori Tomyo, Hirokazu Sakasegawa, Yuta Koizumi, Michio Kuramochi, Masao Yamaguchi & Hiroyuki Nagase. (2021) Comprehensive analysis of allergen-specific IgE in COPD: mite-specific IgE specifically related to the diagnosis of asthma-COPD overlap. Allergy, Asthma & Clinical Immunology 17:1.
Crossref
Crossref
Tara Saco, Israel C. Ugalde, Juan Carlos Cardet & Thomas B. Casale. (2021) Strategies for choosing a biologic for your patient with allergy or asthma. Annals of Allergy, Asthma & Immunology 127:6, pages 627-637.
Crossref
Crossref
Misa Kusumoto & Bryan J. Mathis. (2021) Biologic Treatments for Asthma and Chronic Obstructive Pulmonary Disorder. Allergies 1:2, pages 92-107.
Crossref
Crossref
Stephen Milne, David Mannino & Don D. Sin. (2020) Asthma-COPD Overlap and Chronic Airflow Obstruction: Definitions, Management, and Unanswered Questions. The Journal of Allergy and Clinical Immunology: In Practice 8:2, pages 483-495.
Crossref
Crossref
Diego Jose Maselli & Nicola Alexander Hanania. (2019) Management of asthma COPD overlap. Annals of Allergy, Asthma & Immunology 123:4, pages 335-344.
Crossref
Crossref
Ahmed Yousuf, Wadah Ibrahim, Neil J. Greening & Christopher E. Brightling. (2019) T2 Biologics for Chronic Obstructive Pulmonary Disease. The Journal of Allergy and Clinical Immunology: In Practice 7:5, pages 1405-1416.
Crossref
Crossref
Nicola A. Hanania, Bradley E. Chipps, Noelle M. Griffin, Bongin Yoo, Ahmar Iqbal & Thomas B. Casale. (2019) Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO. Journal of Allergy and Clinical Immunology 143:4, pages 1629-1633.e2.
Crossref
Crossref
Mitsuru Adachi, Masanari Kozawa, Hajime Yoshisue, Ki Lee Milligan, Makoto Nagasaki, Takayoshi Sasajima, Terumasa Miyamoto & Ken Ohta. (2018) Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan. Respiratory Medicine 141, pages 56-63.
Crossref
Crossref
Alexandru Corlateanu, Serghei Covantev, Alexander G. Mathioudakis, Victor Botnaru & Nikolaos Siafakas. (2017) Ashtma-Chronic obstructive pulmonary disease overlap syndrome (ACOS): current evidence and future research directions. COPD Research and Practice 3:1.
Crossref
Crossref
Kristin L. Hines & R. Stokes PeeblesJrJr. (2017) Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence. Current Allergy and Asthma Reports 17:3.
Crossref
Crossref
Yang Xia, Chao Cao, Wen Li & Huahao Shen. (2016) Severe asthma and asthma-chronic obstructive pulmonary disease syndrome. The Lancet 388:10061, pages 2741-2742.
Crossref
Crossref
Tugba Songul Tat & Aykut Cilli. (2016) Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma. Annals of Allergy, Asthma & Immunology 117:5, pages 546-549.
Crossref
Crossref